Suh, H.C.; Rowley, S.D.; Kaur, S.; Lukasik, B.; McKiernan, P.; Boonstra, M.; Baker, M.; DiLorenzo, M.; Skarbnik, A.; Voss, J.;
et al. Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases. Cancers 2025, 17, 1140.
https://doi.org/10.3390/cancers17071140
AMA Style
Suh HC, Rowley SD, Kaur S, Lukasik B, McKiernan P, Boonstra M, Baker M, DiLorenzo M, Skarbnik A, Voss J,
et al. Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases. Cancers. 2025; 17(7):1140.
https://doi.org/10.3390/cancers17071140
Chicago/Turabian Style
Suh, Hyung C., Scott D. Rowley, Sukhdeep Kaur, Brittany Lukasik, Phyllis McKiernan, Michele Boonstra, Melissa Baker, Mary DiLorenzo, Alan Skarbnik, Jason Voss,
and et al. 2025. "Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases" Cancers 17, no. 7: 1140.
https://doi.org/10.3390/cancers17071140
APA Style
Suh, H. C., Rowley, S. D., Kaur, S., Lukasik, B., McKiernan, P., Boonstra, M., Baker, M., DiLorenzo, M., Skarbnik, A., Voss, J., Hampson, A., DeAgresta, B., Boylan, B., Nyirenda, T., Vesole, D. H., & Donato, M. L.
(2025). Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases. Cancers, 17(7), 1140.
https://doi.org/10.3390/cancers17071140
